Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin.

@article{De2014PulmonaryFA,
  title={Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin.},
  author={Aliva De and Igor Guryev and Alejandro LaRiviere and Roberta M. Kato and Choo Phei Wee and Leo Mascarenhas and Thomas G. Keens and Rajkumar Venkatramani},
  journal={Pediatric blood & cancer},
  year={2014},
  volume={61 9},
  pages={
          1679-84
        }
}
BACKGROUND Bleomycin is associated with pulmonary toxic side effects including pneumonitis and pulmonary fibrosis. We evaluated the prevalence of long-term pulmonary function abnormalities in children receiving bleomycin therapy in the context of current chemotherapeutic regimens. METHODS A retrospective review of patients who received bleomycin between January 1999 and December 2011 was conducted. Abnormalities in the most recent pulmonary function test (PFT) at least 1 year after diagnosis… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 3 times. VIEW TWEETS